Skip to main content

Table 3 Patients Using Liquid 16% Intramuscular Immune Serum Globulin*

From: Subcutaneous Immunoglobulin-G Replacement Therapy with Preparations Currently Available in the United States for Intravenous or Intramuscular Use: Reasons and Regimens

     Monthly Dose No. of Infusions Details per Infusion
Patient Patient Age Weight    Per Per Dose Volume No. of Duration mL/kg/
No. Name (yr) (kg) (g) (mg/kg) Week Month (g) (cc) Sites (h) h/site
1 CK 1 10.0 3.2 320 -- 2 1.6 10 1 2 0.500
2 PK 1 11.8 3.2 271 -- 2 1.6 10 1 2 0.424
3 JK 3 18.1 8.0 440 1 5 1.6 10 1 2-3 0.221
4 AP 10 19.5 9.6 492 1 6 1.6 10 1 2 0.256
5 ML 10 27.8 19.2 690 3 12 1.6 10 1 1.5 0.347
6 TS 10 34.0 19.2 556 3 12 1.6 10 1 2 0.147
7 EE 12 36.2 19.2 530 1 4 4.8 30 2 1.5 0.276
8 SJ 3 39.0 16.0 410 2-3 10 1.6 10 1 8 (sleep) 0.032
9 DJ 1 70.7 51 724 2 8 6.4 40 2 4-6 0.056
10 NB 51 77.0 .2 664 2 8 6.4 40 2 3 0.087
11 FW 50 88.6 51.2 558 3-4 15 3.2 20 3 3 0.250
12 NW 46 136.5 48.0 379 1 4 12.8 80 3 3 0.065
  1. *BayGam, unit dose of 1.6 g.
  2. Once per week plus one extra infusion per month.